Last updated on May 2020

Precision Event Monitoring for Patients With Heart Failure Using HeartLogic


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Congestive Heart Failure | Heart failure | Implantable defibrillator | Cardiac Disease | Cardiac Resynchronization Therapy | Cardiovascular Disease | Patient Monitoring | Heart disease
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Subject is age 18 or above, or of legal age to give informed consent specific to each country and national laws.
  • Subject has a documented diagnosis of heart failure.
  • Subject has a Boston Scientific Cardiac Resynchronization Therapy Defibrillator or Implantable Cardioverter Defibrillator device implant that has HeartLogic, with Heart Failure Sensors turned ON, Respiratory Sensor turned ON, and Sleep Incline Sensor turned ON.
  • Subject has an active bipolar right ventricle lead implant.
  • Subject is enrolled in LATITUDE (NXT 5.0 or future version), and is willing to be remotely monitored from the baseline visit for approximately 12 months with HeartLogic disabled.

Exclusion Criteria:

  • Subject has received or is scheduled to receive a heart transplant or ventricular assist device (VAD).
  • Subject is enrolled in any concurrent clinical study without prior Boston Scientific written approval (excluding registries).
  • Subject has a life expectancy of less than 12 months.
  • Subject has a history of non-compliance to medical care or known inability to comply with requirements of the clinical study protocol

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.